| Catalog Number |
EVO-20-25-12.5-E |
| Medical Device Problem Codes |
Off-Label Use (1494); Material Twisted/Bent (2981)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
07/29/2024
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Pma/510(k)#: k162717.Investigation is still pending, a follow up mdr will be submitted to include the investigation conclusions.
|
| |
|
Event or Problem Description
|
|
The material was used following all the rules and steps of the process.When starting the release, the prosthesis locked inside the release system.It did not advance or retract during the trigger pull.Immediately, the doctor reported the problem, as he is an experienced doctor and knows the product well, and informed that he would use a spare prosthesis.He opened a new prosthesis of a different size, the evo-20-25-15-e, and everything went normally and there were no complications.A section of the device did not remain inside the patient¿s body.The patient did not require any additional procedures due to this occurrence.According to the initial reporter, the patient did not experience any adverse effects due to this occurrence.
|
| |
|
Additional Manufacturer Narrative
|
|
Pma/510(k)#: k162717.Investigation is still pending, a follow up mdr will be submitted to include the investigation conclusions.
|
| |
|
Event or Problem Description
|
|
A supplemental report is being submitted due to the clinical input received on 06 aug 2024.The use of evo-20-25-12.5-e device for gastro esophageal fistula treatment is considered an off label use.
|
| |
|
Additional Manufacturer Narrative
|
|
Pma/510(k)#: k162717.Device evaluation: the evo-20-25-12.5-e device of lot number c2121987 involved in this complaint was not returned for evaluation.With the information provided, a document-based investigation was conducted.This complaint is related to (b)(4) which was opened to capture the off-label use of the replacement device.Manufacturing records review: prior to distribution all devices are subjected to a visual inspection and functional inspection to ensure device integrity.A review of the manufacturing records did not reveal any discrepancies that could have contributed to this complaint issue.Instructions for use and/label review: it should be noted that the instructions for use (ifu0061) states the following: ¿this device is used to maintain patency of malignant esophageal strictures and/or to seal tracheoesophageal fistulas¿.It should also be noted that the instructions for use states the following under the ¿equipment required¿ section: ¿.035-inch wire guide¿¿.There is evidence to suggest that the customer did not follow the instructions for use.Image review: an image was not returned for evaluation.Root cause analysis: a definitive root cause of off-label use was identified from the available information.As per information received in the complaint form, the user placed the evo esophageal stent to treat a gastro esophageal fistula which has been deemed off-label use by medical advisor.As per the ifu, the only fistula that the evo-20-25-12.5-e device is indicated to treat are tracheoesophageal fistulas.The off-label use of the device subsequently led to the deployment difficulties reported by the customer.Off label use complaints are considered to be unforeseen misuse.It is unknown how the device will function outside of its intended use.Trending will monitor if any future investigation is required.It should also be noted that an incorrect size wire guide was used with the device.From the information provided, a 0.032-inch wire guide was used as opposed to the recommended 0.035 inch.Confirmation of complaint: the complaint is confirmed based on customer and/or rep testimony.Confirmed quantity of 01 x used device.Corrective action/correction: complaints of this nature will continue to be monitored for similar events.Summary of investigation: according to the initial reporter, the patient did not experience any adverse effects due to this occurrence.The procedure was completed with an evo-20-25-15-e device.
|
| |
|
Event or Problem Description
|
|
Supplemental report is being submitted due to the completion of the investigation on 19-sep-2024.
|
| |
|
Search Alerts/Recalls
|